Although there were several study limitations, our study demonstrated that higher serum DHEA concentrations might predict the patients with BPH or prostate cancer with a Gleason score of ≤ 3 + 4 (≤ GG 2) in men with PSA concentrations of < 10 ng/mL. The gene discussed is KLK3; the disease is benign prostatic hyperplasia.